Menu
ETF
Annual · values202520242023
Operating Cash Flow-6.50 M USD-8.51 M USD-1.18 M USD
Depreciation & Amortization287961 USD267382 USD196937 USD
Stock-Based Compensation1.99 M USD1.13 M USD281538 USD
Capital Expenditures169917 USD396451 USD288712 USD
Cash Flow from Investing-150218 USD-359216 USD-311167 USD
Cash Flow from Financing-27709 USD18.52 M USD1.00 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-6.67 M USD-8.90 M USD-1.47 M USD

Exozymes Inc. operates in the biotechnology sector with a focus on developing enzyme-based products for industrial applications. The primary function of Exozymes Inc. is to leverage advanced enzymatic solutions to enhance processes across various industries, including pharmaceuticals, agriculture, and biofuels. Through its innovative approach, the company aims to improve efficiency, reduce environmental impact, and provide sustainable alternatives to traditional chemical processes. Exozymes Inc. plays a key role in the market by offering customizable enzyme solutions that cater to specific industrial needs, thereby driving technological advancements and promoting cleaner manufacturing practices. Its presence underscores the importance of biotechnology in revolutionizing conventional methods and addressing global environmental challenges.